T Lymphoblastic Leukemia/Lymphoma — Trials

T Lymphoblastic Leukemia/Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

140 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 35
Ph III recruiting: 2
Growth YoY: —
Industry share: 12%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: 48.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 51–64 of 64 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01483690	A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL	terminated	Phase 1 / Phase 2	23	Therapeutic Advances in Childhood Leukemia ConsortiumOTHER	2	Oct 27, 2020	clinicaltrials
NCT00981799	Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL	terminated	Phase 1 / Phase 2	23	Therapeutic Advances in Childhood Leukemia ConsortiumOTHER	7	Oct 1, 2020